logo

Last Update

This profile was last updated on 8/19/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Peter Rothschild?

Peter Rothschild

Chairman

Infant Bacterial Therapeutics AB

Direct Phone: +46 * *** *** **direct phone

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Infant Bacterial Therapeutics AB

Stockholm,

Sweden

Company Description

Infant Bacterial Therapeutics AB ("IBT") is a pharmaceutical company based in Stockholm that develops drugs that meet the needs of the premature infant. IBT's current focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reute...more

Find other employees at this company (6)

Background Information

Employment History

President

BioGaia AB


Affiliations

Diamyd Medical AB

Member


Perlan AB.

Member


Moberg Pharma AB

Board Member


Looft Industries AB

Board Member


Merrill Lynch & Co. Inc

Board Member


Board

Member of Perlan Dialog Och Ledarskap AB


Education

M.Sc.


degree


Web References(196 Total References)


IBT | IBT receives Rare Pediatric Disease Designation from FDA for drug candidate

ibtherapeutics.com [cached]

Peter Rothschild, Chairman of the Board, phone: +46 8 410 145 55
Infant Bacterial Therapeutics AB


IBT | Agenda

ibtherapeutics.com [cached]

Peter Rothschild, Chairman of the Board, IBT


IBT | Board of Directors

ibtherapeutics.com [cached]

Peter Rothschild
Peter Rothschild Chairman of the Board since 2011. Born 1950. Shareholding in the Company: 222 198 series A shares and 241 458 series B shares through Annwall & Rothschild Investments AB, a company co- owned with Peter Rothschild.


IBT | Board of Directors

ibtherapeutics.com [cached]

Peter Rothschild
Peter Rothschild Chairman, M.B.A. Peter Rothschild is Group President and founder of BioGaia together with Jan Annwall. Peter is an experienced entrepreneur and successful businessman. He guided BioGaia's establishment and successful development as Managing Director of BioGaia for 19 years. Peter is also Chairman of the board of directors of several companies including TwoPac AB and MetaboGen AB. Jan founded BioGaia together with Peter Rothschild.


IBT | IBT's rights issue fully subscribed

ibtherapeutics.com [cached]

Peter Rothschild, chairman, phone: +46 8 410 145 55
Infant Bacterial Therapeutics AB (publ)


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory